Hezen Pharmaceuticals Limited, a active public limited company, was established on 27 July 2004 in Hyderabad, Telangana, India. Engaging in general infrastructure services within the manufacturing sector, it holds CIN: U24239TG2004PLC043758. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.50 M.
Formerly known as Hezen Pharmaceuticals Private Limited. It upholds a active non-compliant status. Its leadership includes Raghuveer Laxminarayan Govinda Acharya (Director), Prasad Reddy Kudimuskula (Director), Venkat Reddy Kudimuskula (Director). It holds ₹10.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No.19-79/23, Plot No.23,Balaji Enclave, Uppal,, Hyderabad, Telangana, 500039.
U24239TG2004PLC043758
043758
27 July 2004
₹2.00 Cr
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Hezen Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghuveer Laxminarayan Govinda Acharya | Director | 25 May 2006 | Current |
| Prasad Reddy Kudimuskula | Director | 27 Jul 2004 | Current |
| Venkat Reddy Kudimuskula | Director | 27 Jul 2004 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hezen Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Hezen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹101,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2006 | State Bank Of Hyderabad | ₹6.50 Cr | Open |
| 12 Aug 2005 | Syndicate Bank | ₹1.00 M | Open |
| 01 Jul 2005 | Syndicate Bank | ₹3.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hezen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hezen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hezen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hezen Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Hezen Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Raghuveer Laxminarayan Govinda Acharya was appointed as a Director was appointed as a Director on 25 May 2006 & has been associated with this company since 19 years 7 months . was documented.
Progress on A charge with State Bank Of Hyderabad amounted to Rs. 6.50 Cr with Charge ID 90263015 was registered on 02 Jan 2006. was documented.
A charge with State Bank Of Hyderabad of Rs. 6.50 Cr registered on 02 Jan 2006 with Charge ID 90263015 was modified on 02 Jan 2006. was recorded as a recent event.
The activity A charge with Syndicate Bank amounted to Rs. 0.10 Cr with Charge ID 90262765 was registered on 12 Aug 2005. was completed.
The CIN of Hezen Pharmaceuticals Limited is U24239TG2004PLC043758.
Hezen Pharmaceuticals Limited is headquartered at D.No.19-79/23, Plot No.23,Balaji Enclave, Uppal,, Hyderabad, Telangana, 500039.
Hezen Pharmaceuticals Limited was incorporated on 27 July 2004.
The current directors of Hezen Pharmaceuticals Limited are
The primary industry of Hezen Pharmaceuticals Limited is Manufacturing.
Hezen Pharmaceuticals Limited is unlisted.
The authorized capital of Hezen Pharmaceuticals Limited is ₹2.00 Cr, and the paid-up capital is ₹0.50 M.
The compliance status of Hezen Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX